Headinvest, LLC Novo Nordisk A S Transaction History

Headinvest, LLC

$525 Million
Q3 2024

A detailed history of Headinvest, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Headinvest, LLC holds 119,747 shares of NVO stock, worth $12.4 Million. This represents 2.72% of its overall portfolio holdings.

Number of Shares

119,747

Previous 124,622 3.91%

Holding current value

$12.4 Million

Previous $17.8 Million 19.84%

% of portfolio

2.72%

Previous 3.58%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$119.07 - $145.42 $580,466 - $708,922	-4,875 Reduced 3.91%	119,747 $14.3 Million
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $504,338 - $603,800	-4,110 Reduced 3.19%	124,622 $17.8 Million
Q1 2024 Aug 14, 2024	SELL	$102.11 - $135.92 $804,524 - $1.07 Million	-7,879 Reduced 5.77%	128,732 $16.5 Million
Q4 2023 Feb 12, 2024	SELL	$87.78 - $105.45 $211,286 - $253,818	-2,407 Reduced 1.73%	136,611 $14.1 Million
Q3 2023 Dec 11, 2023	BUY	$90.94 - $199.54 $6.27 Million - $13.7 Million	68,899 Added 98.26%	139,018 $12.6 Million
Q2 2023 Aug 23, 2023	SELL	$155.98 - $172.65 $965,828 - $1.07 Million	-6,192 Reduced 8.11%	70,119 $11.3 Million
Q1 2023 May 17, 2023	SELL	$132.34 - $159.14 $963,038 - $1.16 Million	-7,277 Reduced 8.71%	76,311 $12.1 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $279,243 - $368,503	-2,723 Reduced 3.15%	83,588 $11.3 Million
Q3 2022 Dec 28, 2022	SELL	$95.28 - $116.93 $138,632 - $170,133	-1,455 Reduced 1.66%	86,311 $8.6 Million
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $140,612 - $165,905	-1,362 Reduced 1.53%	87,766 $9.78 Million
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $155,197 - $187,604	-1,667 Reduced 1.84%	89,128 $9.9 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $292,625 - $357,328	-3,052 Reduced 3.25%	90,795 $10.2 Million
Q3 2021 Nov 16, 2021	SELL	$84.42 - $106.62 $72,516 - $91,586	-859 Reduced 0.91%	93,847 $9.01 Million
Q2 2021 Aug 30, 2021	SELL	$67.66 - $84.76 $23,207 - $29,072	-343 Reduced 0.36%	94,706 $7.93 Million
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $173,014 - $195,615	2,580 Added 2.79%	95,049 $6.41 Million
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $212,114 - $245,016	3,320 Added 3.59%	95,789 $6.69 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $212,114 - $245,016	-3,320 Reduced 3.47%	92,469 $6.42 Million
Q3 2020 Nov 24, 2020	SELL	$63.69 - $70.22 $75,472 - $83,210	-1,185 Reduced 1.27%	92,469 $6.42 Million
Q2 2020 Aug 12, 2020	SELL	$58.54 - $67.94 $59,535 - $69,094	-1,017 Reduced 1.07%	93,654 $6.13 Million
Q1 2020 May 12, 2020	SELL	$49.46 - $64.78 $291,022 - $381,165	-5,884 Reduced 5.85%	94,671 $5.7 Million
Q1 2020 May 11, 2020	BUY	$49.46 - $64.78 $255,559 - $334,718	5,167 Added 5.42%	100,555 $6.05 Million
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $18,099 - $21,148	363 Added 0.38%	95,388 $5.52 Million
Q3 2019 Nov 21, 2019	SELL	$47.54 - $53.43 $205,610 - $231,084	-4,325 Reduced 4.35%	95,025 $4.91 Million
Q2 2019 Aug 22, 2019	SELL	$46.79 - $52.47 $56,381 - $63,226	-1,205 Reduced 1.2%	99,350 $5.07 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $4.79 Million - $5.44 Million	-103,275 Reduced 50.67%	100,555 $5.26 Million
Q4 2018 Feb 22, 2019	BUY	$41.54 - $47.25 $4.11 Million - $4.68 Million	98,990 Added 94.42%	203,830 $9.39 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $935 - $1,024	-20 Reduced 0.02%	104,840 $4.94 Million
Q2 2018 Aug 09, 2018	SELL	$44.29 - $50.42 $58,241 - $66,302	-1,315 Reduced 1.24%	104,860 $4.84 Million
Q1 2018 Apr 09, 2018	SELL	$48.49 - $58.14 $20,608 - $24,709	-425 Reduced 0.4%	106,175 $5.23 Million
Q4 2017 Jan 30, 2018	SELL	$47.53 - $53.73 $120,488 - $136,205	-2,535 Reduced 2.32%	106,600 $5.72 Million
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $4.49 Million - $5.37 Million	109,135	109,135 $5.43 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $233B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.

Account